# Circular Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/circular-genomics

- Industry: Biotechnology
- Headquarters: Albuquerque, US
- Website: www.circulargenomics.com
- Total disclosed funding: $28M
- Latest round: Series A (Dec 1, 2025)
- Investors on record: 7

## About

Based in New Mexico, US, and founded in 2021 by co-founders Nikolaos Mellios, Alexander Hafez, and Kosmas Karadimitriou, Circular Genomics Inc. operates as a genomics company providing diagnosis and treatment of psychiatric and neurological disorders through development of circular RNA biomarkers. In December 2025, Circular Genomics, Inc. raised USD 15 million in series A funding led by Mountain Group Partners, with participation from Alzheimer's Drug Discovery Foundation, Poplar Grove Investors and HIP Fund. Circular Genomics Inc. developed a product, that is a blood-based assay that analyzes circular RNA biomarkers to predict a patient's response to selective serotonin reuptake inhibitor (SSRI) antidepressants before treatment initiation. The company’s diagnostic tool expedites treatment by identifying the most effective medication, thereby increasing the likelihood of patient recovery and reducing the trial-and-error approach commonly associated with psychiatric treatment. It uses circular RNA biomarkers to offers a enrichment in neural tissue, allowing for non-invasive, accurate, and dynamic monitoring of brain disorders. The company will use the December 2025 funding to expand clinical validation, improve its biomarker platform, form partnerships, and hire key team members.

## Funding rounds

- Series A, Dec 1, 2025, $15M — Mountain Group Partners, Alzheimer's Drug Discovery Foundation, HIP, Poplar Grove Investors
- Series A, Jan 11, 2024, $8.3M — Cottonwood Technology Fund, Mountain Group Partners, Tramway Venture Partners, UNM Rainforest Innovations
- Seed, Dec 15, 2021, $4.5M — Cottonwood Technology Fund, Mountain Group Partners, Tramway Venture Partners

## Investors

- Cottonwood Technology Fund (https://capitalatlas.ai/funds/cottonwood-technology-fund) — Seed, Series A
- Mountain Group Partners (https://capitalatlas.ai/funds/mountain-group-partners) — Seed, Series A
- Tramway Venture Partners (https://capitalatlas.ai/funds/tramway-venture-partners) — Seed, Series A
- UNM Rainforest Innovations — Series A
- Alzheimer's Drug Discovery Foundation — Series A
- HIP (https://capitalatlas.ai/funds/hip) — Series A
- Poplar Grove Investors — Series A